Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-10 Sale | 2024-12-11 5:17 pm | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $9.4622 | $283,866 | 747,663 (Direct) | View |
| 2024-11-26 Sale | 2024-11-27 7:39 pm | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $9.27 | $278,100 | 777,663 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-08 Equity Swap | 2025-01-10 4:10 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Malin Life Sciences Holdings Ltd 10% Owner | 11,835,673 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:17 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Amado Rafael Director | 58,950 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:17 pm | N/A 2033-04-30 | Poseida Therapeutics Inc. | PSTX | Amado Rafael Director | 82,550 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:17 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Corning Luke Director | 58,950 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:17 pm | N/A 2031-08-24 | Poseida Therapeutics Inc. | PSTX | Corning Luke Director | 129,033 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:16 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 58,950 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:16 pm | N/A 2028-07-16 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 197,147 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:15 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director | 68,950 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:15 pm | N/A 2029-01-02 | Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director | 197,147 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:14 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director | 58,950 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:14 pm | N/A 2031-07-22 | Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director | 170,640 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:12 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director | 78,600 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:12 pm | N/A 2032-06-15 | Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director | 111,700 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:11 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 254,852 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:11 pm | N/A 2028-02-05 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 575,860 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:10 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Rizvi Syed Ali-aamir Chief Medical Officer | 185,000 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:10 pm | N/A 2034-03-31 | Poseida Therapeutics Inc. | PSTX | Rizvi Syed Ali-aamir Chief Medical Officer | 250,000 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:09 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer | 223,640 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:09 pm | N/A 2030-07-08 | Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer | 606,936 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:08 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO | 636,726 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:08 pm | N/A 2028-03-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J President and CEO | 1,760,996 | $0 | 0 (Direct) | View |
| 2025-01-08 Equity Swap | 2025-01-08 2:07 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Yarema Kristin President and CEO | 615,836 | $0 | 0 (Direct) | View |
| 2025-01-08 Disposition | 2025-01-08 2:07 pm | N/A 2033-04-10 | Poseida Therapeutics Inc. | PSTX | Yarema Kristin President and CEO | 843,525 | $0 | 0 (Direct) | View |
| 2025-01-02 Tax Withholding | 2025-01-03 8:24 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 23,313 | $9.6 | 630,726 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-11 5:17 pm | N/A 2028-03-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $0 | 747,663 (Direct) | View |
| 2024-12-10 Exercise | 2024-12-11 5:17 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $2.781 | 747,663 (Direct) | View |
| 2024-11-26 Exercise | 2024-11-27 7:39 pm | N/A 2028-03-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $0 | 777,663 (Direct) | View |
| 2024-11-26 Exercise | 2024-11-27 7:39 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 30,000 | $2.781 | 777,663 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:16 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:16 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director | 47,000 | $0 | 96,300 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:15 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Corning Luke Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:14 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:13 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director | 47,000 | $0 | 105,950 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-18 4:12 pm | N/A 2034-06-16 | Poseida Therapeutics Inc. | PSTX | Amado Rafael Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 4:03 pm | N/A 2034-03-31 | Poseida Therapeutics Inc. | PSTX | Rizvi Syed Ali-aamir Chief Medical Officer | 435,000 | $0 | 435,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:29 pm | N/A 2034-02-28 | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 192,443 | $0 | 357,983 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:29 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Mylet Johanna Chief Financial Officer | 18,091 | $4.13 | 357,983 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 34,157 | $4.13 | 651,291 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:18 pm | N/A 2034-02-28 | Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer | 192,443 | $0 | 326,340 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | LEONHARDT HARRY J GC & Chief Compliance Officer | 16,306 | $4.13 | 326,340 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:18 pm | N/A 2034-02-28 | Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy | 192,443 | $0 | 530,740 (Direct) | View |
| 2024-03-01 Tax Withholding | 2024-03-04 5:18 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy | 35,739 | $4.13 | 530,740 (Direct) | View |
| 2024-02-01 Tax Withholding | 2024-02-02 8:51 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 47,162 | $3.41 | 685,448 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:03 pm | N/A 2034-01-01 | Poseida Therapeutics Inc. | PSTX | Yarema Kristin President and CEO | 595,200 | $0 | 952,036 (Direct) | View |
| 2024-01-02 Option Award | 2024-01-04 4:02 pm | N/A 2034-01-01 | Poseida Therapeutics Inc. | PSTX | Gergen Mark J Executive Chairman | 297,600 | $0 | 905,210 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:10 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Collins Cynthia Director | 47,000 | $0 | 66,650 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:09 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Schmid John P. Director | 47,000 | $0 | 66,650 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:09 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Lloyd Marcea Bland Director | 47,000 | $0 | 76,650 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:08 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | BAUM CHARLES M Director | 47,000 | $0 | 86,300 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-16 4:07 pm | N/A 2033-06-14 | Poseida Therapeutics Inc. | PSTX | Corning Luke Director | 47,000 | $0 | 66,650 (Direct) | View |
| 2023-05-01 Option Award | 2023-05-02 4:14 pm | N/A 2033-04-30 | Poseida Therapeutics Inc. | PSTX | Amado Rafael Director | 94,500 | $0 | 94,500 (Direct) | View |
| 2023-04-11 Option Award | 2023-04-12 4:49 pm | N/A 2033-04-10 | Poseida Therapeutics Inc. | PSTX | Yarema Kristin President, Cell Therapy | 855,161 | $0 | 855,161 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-02 6:30 pm | N/A 2033-02-28 | Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy | 218,055 | $0 | 499,319 (Direct) | View |
| 2023-03-01 Tax Withholding | 2023-03-02 6:30 pm | N/A N/A | Poseida Therapeutics Inc. | PSTX | Warner Brent President, Gene Therapy | 26,617 | $5.35 | 499,319 (Direct) | View |